Top 30 Biotechnology Companies in Globe 2025: Statistics View by Spherical Insights and Consulting
RELEASE DATE: Jul 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Biotechnology Market Size is projected to Grow from USD 1.76 Trillion in 2024 to USD 7.23 Trillion by 2035, at a CAGR of 13.71% during the forecast period 2025–2035. The biotechnology market is expanding rapidly due to advances in big data, AI, and machine learning, which improve research and development capacities. Furthermore, the rise of personalised medicine, orphan drug development, and the emergence of breakthrough biotech startups are broadening applications and boosting worldwide investment and market revenue growth.
Introduction
The global biotechnology market refers to the formation and development of biological systems and organisms in healthcare, agriculture, and industry, propelled by innovation, personalised medicine, and the rising need for long-term solutions. The global biotechnology market is expanding rapidly, driven by advances in personalised medicine, orphan drug research, and vaccine innovation, particularly in light of the success of mRNA COVID-19 vaccines. The sector benefits from the expansion of agricultural applications enabled by genetically modified crops and tissue culture technologies. Increasing demand for chronic disease treatments, combined with considerable investments in gene and cell therapies, drives growth. Fermentation technology innovations, such as improved bioreactors, are increasing output capacity. The advancements in CAR T and TCR T-cell treatments are establishing a path in chronic viral infection treatment. The rising acceptance of stem cell techniques, DNA fingerprinting, and genetic modification in the areas of healthcare, forensic science, and agriculture will continue to grow the market. Funders are supporting and extending a strong clinical pipeline and continuing to advance the complex and technologically advanced global biotechnology stage.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Biotechnology Market.
Biotechnology Market Size & Statistics
- The Market Size for Biotechnology was Estimated to be Worth USD 1.76 Trillion in 2024.
- The Market Size is Going to Expand at a CAGR of 13.71% between 2025 and 2035.
- The Global Biotechnology Market Size is Anticipated to Reach USD 7.23 Trillion by 2035.
- North America is Expected to generate the highest demand during the forecast period in the Biotechnology market.
- Asia Pacific is Expected to Grow the fastest during the forecast period in the Biotechnology market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Biotechnology market.
The biotechnology market in the Asia Pacific is projected to experience the fastest CAGR during the forecast period. The regional biotechnology market is witnessing strong growth due to increased investments, enhanced healthcare infrastructure, and supportive government policies. Key players are also pursuing expansion strategies to strengthen their presence. For example, in February 2022, Moderna Inc. announced plans to expand its commercial footprint in Asia by establishing new subsidiaries in Malaysia, Singapore, Hong Kong, and Taiwan. Strategic biopharmaceutical partnerships, such as the collaboration between Kiniksa Pharmaceuticals and Huadong Medicine for the development and commercialization of ARCALYST and mavrilimumab in the Asia-Pacific, are further accelerating market growth. In India, the biotechnology sector is primarily driven by its healthcare applications, especially recombinant therapeutics and vaccines. As of December 2023, Biospectrum reported that India was a leading global supplier of BCG, DBT, and measles vaccines, reinforcing its pivotal role in the global biotechnology landscape.
North America is expected to generate the highest demand during the forecast period in the Biotechnology market.
North America is expected to lead the biotechnology market from 2024 to 2035. The regional market is in expansion mainly due to large competitors offering capital investments and R&D, and high healthcare spending. The region has significant amounts of genomics, proteomics, and cell biology platforms, which are promoting and speeding the acceptance of life sciences technology. The region can expect to see significant increases in market growth due to high numbers of chronic diseases and personalized medicine applications for life-threatening conditions.
Top 10 Biotechnology Trends
- Personalized Medicine
- CRISPR and Gene Editing
- Cell and Gene Therapy
- mRNA Technology Beyond COVID-19
- Artificial Intelligence and Big Data Integration
- Biomanufacturing and Synthetic Biology
- Microbiome Research
- Agricultural Biotechnology
- Digital Health and Wearables Integration
- Green Biotechnology and Environmental Applications
1. Personalized Medicine
Advances in genomics and data analytics enable personalised treatments based on individual genetic profiles. This technique improves therapy efficacy while reducing side effects, particularly in cancer and uncommon disorders.
2. CRISPR and Gene Editing
CRISPR-Cas9 and other gene-editing technologies enable scientists to change genes with great precision. These techniques are revolutionising genetic research and therapy development for conditions such as sickle cell anaemia, cancer, and hereditary disorders.
3. Cell and Gene Therapy
Biotech companies are spending extensively on regenerative medicine, which includes CAR-T medicines and stem cell treatments. These medicines have the potential to cure chronic and life-threatening ailments like cancer and neurological disorders.
4. mRNA Technology Beyond COVID-19
It offers quicker and more adaptable development pipelines. mRNA technology is currently being investigated for additional infectious diseases, cancer immunotherapy, and uncommon genetic problems after its success in COVID-19 vaccines.
5. Biomanufacturing and Synthetic Biology
Biomanufacturing is the process of creating materials, chemicals, and medicines using biological systems. This is furthered by synthetic biology, which modifies organisms to produce biofuels, enzymes, or even lab-grown meat.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the biotechnology market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 14 Companies Leading the Biotechnology Market
- AstraZeneca
- Gilead Sciences, Inc.
- Bristol-Myers Squibb
- Sanofi
- Biogen
- Abbott Laboratories
- Pfizer, Inc.
- Amgen Inc.
- Novo Nordisk A/S
- Merck KGaA
- Johnson & Johnson Services, Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd.
- Lonza
- Others
1. AstraZeneca
Headquarters – Cambridge, United Kingdom
AstraZeneca is an innovative worldwide biopharmaceutical company, committed to discovering, developing, and commercializing prescription medicines in oncology, cardiovascular, renal, metabolism, and respiratory. AstraZeneca is actively advancing biotechnology solutions with exceptional science, including mRNA, monoclonal antibodies, gene therapy, etc., as part of their drug development pipeline. The company collaborates with research organizations and biotech companies all over the world to advance innovation and patient health. AstraZeneca was involved in the development of the COVID-19 vaccine and continues to invest in biologics and personalised medicine to respond to complex, chronic, and rare diseases.
2. Bristol-Myers Squibb
Headquarters – Princeton, New Jersey, USA
Bristol-Myers Squibb (BMS) is committed to finding, creating, and distributing cutting-edge medications in important therapeutic areas such as neuroscience, immunology, cardiovascular disease, and oncology. The business has significant investments in biotechnology, specifically in gene therapy, cell therapy, and biologics. BMS keeps growing its biotech expertise through partnerships with businesses like BioNTech and significant acquisitions like Celgene. Its dedication to innovative research and strategic partnerships enhances its ability to promote personalised medicine and game-changing therapies that tackle significant unmet medical needs around the world.
3. Pfizer, Inc.
Headquarters – New York, USA
Leading pharmaceutical and biotechnology company Pfizer, Inc. is renowned for creating cutting-edge treatments in the fields of immunology, rare diseases, vaccines, and oncology. It became well-known throughout the world for its COVID-19 mRNA vaccine, which was created in partnership with BioNTech. Through strategic acquisitions like Seagen and investments in cutting-edge biologics and gene therapies that target haemophilia, cancer, and neuromuscular illnesses, Pfizer is continuing to broaden its biotechnology presence. Early-stage biotech companies are supported by the company's Breakthrough Growth Initiative, which prioritises cutting-edge technology and personalised treatment. Pfizer continues to lead the world in biopharmaceutical innovation due to its robust R&D pipeline and dedication to revolutionary health solutions.
4. Amgen Inc.
Headquarters – Thousand Oaks, California, USA
Amgen Inc. is a leading biotechnology company in the world that specialises in creating cutting-edge biologic treatments for diseases like cancer, heart disease, inflammation, and other ailments. Amgen has significant R&D capabilities, a solid therapeutic pipeline, and ongoing investments in cutting-edge science and digital innovation. The company has opened a new Technology and Innovation Centre in Hyderabad, India, furthering its global reach. Amgen further highlights its dedication to precision medicine and the improvement of global health by emphasising the use of human genetics to guide drug discovery to create highly targeted and efficient treatments.
5. Merck KGaA
Headquarters – Darmstadt, Germany
Merck KGaA focuses on performance materials, life sciences, and healthcare. In the field of biotechnology, it concentrates on immunology, neurology, and oncology, with a particular focus on advanced cell and gene treatments, biologics, and biosimilars. Merck promotes biotech innovation through its Life Science business by providing technologies and resources for drug research and manufacture. The business puts a lot of money into research and development and works with international partners to speed up biotech innovations, putting it at the forefront of scientific progress and individualised medical care.
Are you ready to discover more about the Biotechnology market?
The report provides an in-depth analysis of the leading companies operating in the global biotechnology market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- AstraZeneca
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Gilead Sciences, Inc.
- Bristol-Myers Squibb
- Sanofi
- Biogen
- Abbott Laboratories
- Pfizer, Inc.
- Amgen Inc.
- Novo Nordisk A/S
- Merck KGaA
- Johnson & Johnson Services, Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd.
- Lonza
- Others
Conclusion
The global biotechnology market is expected to expand significantly, driven by increased demand for targeted medicines, personalised medicine, and advanced biotechnological solutions in healthcare, agriculture, and the environment. The rising prevalence of chronic diseases, advances in genetic engineering, and the effectiveness of mRNA and cell-based therapies are altering the therapy landscape. Government funding, smart collaborations, and strong R&D pipelines are boosting innovation. Major corporations such as Amgen, Pfizer, and Bristol-Myers Squibb are increasing their biotech capabilities to meet unmet medical requirements. As biotechnology techniques continue to transform diagnostics, medication research, and crop yield, the market will play an increasingly important role in enhancing global health, food security, and sustainability. Biotechnology is emerging as an important pillar of future global progress, thanks to significant investments, governmental support, and scientific advancements.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?